Bridging the Gap between Point-of-Care Testing and Laboratory Testing in Hemostasis

Abstract

Point-of-care (POC) testing within hemostasis is an expanding field, with the most widely used test being POC international normalized ratio (INR). Many of these devices are being used in a nonlaboratory setting by staff with no laboratory training. In the United Kingdom, external quality assessment (EQA) is provided by the organization UK National External Quality Assessment Scheme for Blood Coagulation (UK NEQAS BC). Participants within the UK NEQAS BC POC INR program are largely based in primary care (77%), with the majority of EQA samples and patients tests being performed by nurses (70%). Many of these centers do not have support from the laboratory staff and may, therefore, not understand the requirement for a robust quality control (QC) system comprising both internal quality control (IQC) and EQA. From data acquired through a questionnaire of these UK NEQAS BC users, we observed that 2% of the centers never perform IQC tests, only 29% perform IQC tests when starting a new batch of test strips, and just 15% carry out IQC with each clinic as recommended by the UK guidelines. The imprecision of EQA tests was greater for POC users than in the UK NEQAS BC hospital laboratory program, with average coefficients of variation for a 2-year period of 11.0 and 7.3%, respectively. This may reflect the handling of EQA samples rather than the imprecision of the method, due to the lack of laboratory training amongst POC staff. POC INR in the UK could greatly benefit from more interaction and support from laboratories to these POC testers.

Keywords

point of care - INR monitoring - primary care - secondary care

• References

• 1 Oake N, Jennings A, Forster AJ, Fergusson D, Doucette S, van Walraven C. Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ 2008; 179 (3) 235-244
• 2 Kitchen S, Preston FE. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy. Semin Thromb Hemost 1999; 25 (1) 17-25
• 3 Keeling D, Baglin T, Tait C , et al; British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol 2011; 154 (3) 311-324
• 4 Ansell J, Hirsh J, Hylek E , et al. American College of Chest Physicians. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, suppl): 160S-198S
• 5 Baglin TP, Cousins D, Keeling DM, Perry DJ, Watson HG. Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. Br J Haematol 2007; 136 (1) 26-29
• 6 Kitchen S, Gray E, Mackie I, Baglin T, Makris M ; BCSH committee. Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology. Br J Haematol 2014; 166 (6) 830-841
• 7 Lippi G, Favaloro EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus?. Clin Chem Lab Med 2015; 53 (2) 185-197
• 8 Jennings I, Kitchen D, Keeling D, Fitzmaurice D, Heneghan C ; BCSH Committee. Patient self-testing and self-management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology. Br J Haematol 2014; 167 (5) 600-607 [Epub ahead of print]
• 9 Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Br J Haematol 2010; 150 (5) 501-514
• 10 Stavelin A, Meijer P, Kithcen D, Sandberg S. External quality assessment of point of care International Normalized Ratio (INR) testing in Europe. Clin Chem Lab Med 2011; 50 (1) 81-88
• 11 Management and Use of IVD Point of Care Test Devices Medical Devices Agency Bulletin 2010 www.gov.uk
• 12 Briggs C, Guthrie D, Hyde K , et al; British Committee for Standards in Haematology General Haematology Task Force. Guidelines for point-of-care testing: haematology. Br J Haematol 2008; 142 (6) 904-915
• 13 Poller L, Keown M, Ibrahim S , et al; European Action on Anticoagulation (EAA). A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. Thromb Haemost 2009; 101 (3) 487-494
• 14 Kitchen DP, Kitchen S, Jennings I , et al. Point of care testing by healthcare professionals: current practice amongst the UK National External Quality Assessment Scheme participants. Br J Haematol 2005; 130 (2) 320-321
• 15 Fitzmaurice DA, Gardiner C, Kitchen S, Mackie I, Murray ET, Machin SJ ; British Society of Haematology Taskforce for Haemostasis and Thrombosis. An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation. Br J Haematol 2005; 131 (2) 156-165
• 16 Kitchen DP, Kitchen S, Jennings I , et al. Point of Care INR testing devices: performance of the Roche CoaguChek XS and XS Plus in the UK NEQAS BC external quality assessment programme for healthcare professionals: four years' experience. J Clin Pathol 2012; 65 (12) 1119-1123